Apparatus and method for identifying one or more amyloid beta plaques in a plurality of discrete oct retinal layers
AssigneeNeuroVision Imaging LLC
InventorSteven Roger Verdooner
Life of this patent
Estimating the term…
Abstract
The present invention is an apparatus to produce an OCT of an eye or a brain of a patient to identify one or more plaques in a plurality of discrete OCT retinal layers. The present invention also includes a plurality of methods for identifying one or more plaques in a plurality of discrete OCT retinal layers that can include a contrast agent and a normative database.
Claims25
An apparatus to produce an image of an eye of a patient to identify one or more amyloid beta plaques and amyloid containing drusen in a plurality of discrete OCT retinal layers, comprising:
- an OCT system;
- and
- a computer system that processes data and controls said apparatus that is in communication with said OCT system.
A method for identifying one or more amyloid beta plaques and amyloid containing drusen in a plurality of discrete OCT retinal layers, comprising the steps of:
- identifying one or more A[beta] peptides located above a retinal pigment epithelium thereby differentiating said one or more A[beta] peptides from said drusen;
- imaging said mammal's retina with an OCT system, a multispectral, a hyperspectral imaging or an Autofluorescence imaging device;
- examining said images of said A[beta] peptides;
- quantifying an increase or a decrease of said A[beta] peptides in said mammal's retina;
- and
- rendering a prognosis based upon a level of said A[beta] peptides in the mammal's retina based on identifying one or more plaques in a plurality of discrete OCT retinal layers above said retinal pigment epithelium.
A method for identifying one or more amyloid beta plaques and amyloid containing drusen in a plurality of discrete OCT retinal layers with a contrast agent and a normative database, comprising the steps of:
- administering and staining a plurality of A[beta] peptides;
- imaging said mammal's retina with an OCT system by identification of a spectral signature and retinal layer segmentation of amyloid in an OCT data set or one or more other modalities;
- examining said images of said stained A[beta] peptides;
- quantifying an increase or a decrease of said stained A[beta] peptides in said mammal's retina;
- and
- rendering a prognosis based upon a level of said stained A[beta] peptides in said mammal's retina identifying said one or more plaques in said discrete OCT retinal layers.
Dependencies are inferred from the claim text.